Tempus Priority Study: A Pan-tumor Observational Study

Clinical trial NCT05179824 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05179824
Sponsor: Tempus AI
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Prostate Cancer Bladder Cancer Lung Cancer Brain Cancer Pancreatic Cancer Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Cancer of Liver Cancer of Colon Cancer of Head and Neck

Start date: 2020-10-19
Primary completion: 2026-10-19
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.